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Introduction: The morbidity and mortality of patients undergoing bowel transit reconstruc-
tion  reach signiﬁcant values. Perhaps this and other factors could explain why 30–60% of
patients end up with deﬁnitive ostomies, even those with initially temporary ostomies, due
to the procedure risks.
Objective:  To analyze retrospectively the medical records of patients undergoing bowel tran-
sit  reconstruction in one of the SUS referral hospitals in São Paulo from October 2008 to
December  2011.
Results:  The mean age of our patients was 53.9 years and 54% of those 100 patients stud-
ied  between October 2008 and December 2011 had signiﬁcant comorbidity. The indication
for  creating an initial ostomy was malignancy in 43%, and the mean stoma duration 14.3
months.  The mortality rate was 6%.
Conclusion: Although the bowel transit reconstruction is a procedure quite desired by
patients,  its indication should be carefully evaluated, with an appropriate consent from
the  patient.© 2013 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND Study conducted by the Medical Residency Program of Coloproctology, Department of General Surgery, Hospital Santa Marcelina, São
Paulo, SP, Brazil.
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Análise  retrospectiva  dos  pacientes  submetidos  à  reconstruc¸ão  de  trânsito
intestinal  em  hospital  terciário  de  referência  da  zona  leste  de  São  Paulo
Palavras-chave:
Ostomia
Reconstruc¸ão  de trânsito
intestinal
Morbi-mortalidade
r  e  s  u  m  o
Introduc¸ão: A morbi-mortalidade de pacientes submetidos à reconstruc¸ão  de trânsito intesti-
nal alcanc¸a  valores signiﬁcativos e, por esse e outros fatores, talvez se explique o fato que
de 30 a 60% dos portadores de ostomia intestinal terminal passam a possuí-la de maneira
deﬁnitiva, apesar de, na maior parte das vezes, ela ser realizada como procedimento pro-
visório com o argumento de maior seguranc¸a  do paciente.
Objetivo: Analisar retrospectivamente os dados de prontuário de pacientes submetidos à
reconstruc¸ão  de trânsito intestinal em um dos hospitais de referência do SUS na cidade de
São Paulo no período de outubro de 2008 a dezembro de 2011.
Resultados:  A média de idade dos pacientes foi de 53,9 anos e 54% dos 100 pacientes estuda-
dos no período de outubro de 2008 e dezembro de 2011 padeciam de alguma comorbidade. A
indicac¸ão  para confecc¸ão  da ostomia inicial decorreu de doenc¸a  maligna em 43% e o tempo
médio de permanência com o estoma foi de 14,3 meses. A taxa de mortalidade foi de 6%.
Conclusão: Embora a reconstruc¸ão  do trânsito intestinal seja um procedimento bastante
desejado pelos pacientes, sua indicac¸ão  deve ser bastante criteriosa, com consentimento
adequado  por parte do paciente.
© 2013 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
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ince the ﬁrst description of colostomy by the French physi-
ian  Littré, the use of ostomy and their indications were
odiﬁed through the ages. However, the morbidity and mor-
ality  associated with bowel transit restoration are still cause
or  concern. In this regard, it is known that overall mor-
idity  rates can reach 50%, and mortality rates vary from 0
nd  4.5%.1–3 However, when speciﬁcally analyzing patients
ho  underwent bowel transit reconstruction with a previous
artmann-type ostomy, the values of mortality can reach up to
8%.4,5
The operation initially described in 1921 by Henri Hart-
ann  Albert is of fundamental importance in cases of
mergency colorectal surgery and, in addition, it must be
mphasized  that this type of procedure is commonly per-
ormed  on patients with severe conditions,6 such that only
bout  30–60% of these patients are referred to bowel tran-
it  reconstruction.4,5 However, one must keep in mind that,
ccording  to Vaid et al., 32.3% of patients undergoing ini-
ial  surgery with Hartmann-type terminal colostomy failed in
heir bowel transit reconstruction.7
These percentages demonstrate the importance of deter-
ining  the factors that inﬂuence the clinical outcome of
atients  undergoing surgical bowel transit reconstruction.
mong these factors, there is the procedure performed at the
nitial  operation and the complications of this procedure,8
he surgical technique used in the restoration of bowel
ontinuity and the experience of the surgeon, the type
9terminal- or loop-) of ostomy and the conscious use
f  antibiotics and the pre- and postoperative care,10 in
ddition to the risk factors associated with the patient
tself.Objectives
To analyze retrospectively data obtained from electronic
medical records of patients who underwent bowel transit
reconstruction in one of SUS referral Teaching Hospitals in
São  Paulo.
Patients  and  methods
This is a retrospective study conducted between October 2008
and  December 2011 involving 100 patients treated, monitored
and  operated by the Medical Residency Service of Coloproctol-
ogy,  Hospital Santa Marcelina, São Paulo.
We sought to analyze data obtained from electronic medi-
cal  records in relation to gender, age, comorbidities (including
smoking), anesthetic risk classiﬁcation (ASA), mean ostomy
duration  primary indication (benign or malignant disease),
type  of anesthesia used for bowel transit reconstruction, mor-
tality  and mean in-hospital length of stay.
The study was  conducted at the Coloproctology Service,
Hospital Santa Marcelina, São Paulo, and approved by the Eth-
ical  Committee under No. 27/13.
Results
In the study period, between October 2008 and December 2011,
the  Medical Residency Service of Coloproctology, Hospital
Santa  Marcelina, São Paulo, performed 264 elective colorec-
tal  operations, comprising 100 bowel transit reconstructions
(37.8%).
The mean age of patients was  53.9 years (15–82 years) and
57%  were  male (Fig. 1). With regard to comorbidities, they were
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Gender
Female
43%
Male
57%
30%
56%
14%
ASA I ASA II ASA IIIFig. 1 – Gender distribution.
present in 54 patients, mainly hypertension, diabetes melli-
tus,  smoking and Chagas disease. Among those patients with
comorbidity,  23 (42.6%) had an association of two or more  med-
ical  conditions.
The indication for the initial ostomy creation was  malig-
nant  disease in 43% (Fig. 2) and the mean stoma duration was
14.3  months. Fifty-two patients had terminal ostomy, notably
of  Hartmann type. Regarding the classiﬁcation of anesthetic
risk  (ASA), 30% were ASA I, 56% were  ASA II and 14% were
ASA  III (Fig. 3). On the other hand, when stratifying the initial
indication  for stoma construction, 15% of these surgeries can
be  considered as scheduled procedures, particularly diverting
colorectal  anastomosis.
General  anesthesia was  used in 40% of patients, peripheral
block  in 34% and an association between both types in 26% of
patients.
Complications  in the surgical procedure occurred in 3% of
patients,  and none of these progressed to death. Six percent
of  the patients undergoing bowel transit reconstruction died,
and  66.7% of these deceased patients had been treated with a
Hartmann-type terminal colostomy (Fig. 4) and 75% of them
57%
43%
Malignant disease Benign disease
Fig. 2 – Initial indication of stoma construction.Fig. 3 – Classiﬁcation of anesthetic risk.
had been reoperated, due to anastomotic dehiscence followed
by  fecal peritonitis.
The  mean in-hospital length of stay time was 7.66 days,
with  a range of 4–36 days. However, when one looks specif-
ically  at the hospitalization time among patients in whom
clinical  or surgical complications occurred but not progressed
to  death, this mean time was  27.25 days.
Discussion
In the present study, the mean age stands in the 5th decade.
This  ﬁnding is likely to reﬂect the percentage of malignant dis-
eases  as a cause for stoma indication (43%). However, when
one  analyzes studies whose main cause for ostomy creation
was  some traumatic injury (i.e., a gunshot), a lower mean
age4,11 was found, which may  inﬂuence the ﬁnal results for
morbidity and mortality.
Melotti  et al.12–16 studied 273 ostomized patients between
2000 and 2010 and found a mean age of 64.5 years with 53.1%
of  patients being female. It has been shown, as in our study,
that  the main indication for ostomy creation was colorectal
cancer, accounting for 45.8% of cases.
Loop
33%
Hartmann
67%
Mortality by type of ostomy
Fig. 4 – Overall mortality and mortality stratiﬁed by type of
ostomy.
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The mean ostomy duration in our study was  similar to
ther  results found in national literature.6 Silva et al.13 noted
 mean ostomy duration of 15.7 months (3–284 months). How-
ver,  this duration undergoes variation, mainly due to the
nitial  indication for the intestinal diversion, for example, neo-
lastic disease, the need for adjuvant chemotherapy6 and also
o  an overload of the health service system capacity.4
We  found similar hospital length of stay to those described
n  the literature. In addition, studies show a longer in-
ospital  period in cases with surgical times over 300 min,
ntra-operative adhesions, bowel lesions during surgery, ana-
tomotic ﬁstulae, abdominal wall infections and the need for
ntensive Care Unit use.6 In our study, all patients that had
pent  more  than 10 days of in-hospital length of stay were
hose  undergoing reoperation.
As regards to mortality analysis, our overall rate was  6%,
ith  4.1% for cases of loop ostomy and 7.7% for terminal
stomy. When reviewing the literature, it appears that a
reater  number of overall deaths occurred in our study com-
aring  to other published studies. However, it should be borne
n  mind that our patients were older than those in the stud-
es  reviewed and, in addition, our patients who died were
lso  older (67.5 years). Furthermore, it should be empha-
ized  that one of the patients who  died after terminal ostomy
econstruction had actinic disease, and perhaps in this case
he  surgical indication could be revised, as occurs in cases
escribed  in the literature.6
Bocic et al.14 observed a mortality rate of 1.7%. In Brazil,
abr-Gama15 had an overall rate of 3.6%. Bahten et al.4 had
ne  death after bowel transit reconstruction among a total of
2  patients (2.3%). However, when the mortality for surgical
econstruction of bowel transit after an initial Hartmann pro-
edure  is analyzed, our data are consistent with the literature,
ith  rates up to 28%.5,6
When stratifying the patients who  died, the mean age was
7.5  years, ranging between 52 and 79 years. The gender dis-
ribution  was  equivalent, and 4 of 6 patients (66.7%) exhibited
erminal  ostomy. In this group of patients, we  found that only
ne  had no comorbidities (16.7%), including cases of smoking.
These  reported percentages show the importance of deter-
ining  the factors that inﬂuence the clinical outcome of
atients  undergoing surgical reconstruction of bowel transit.
mong  these factors, stand out the procedure performed at
he  initial operation and the complications of this procedure,
he  surgical technique used in the restoration of bowel con-
inuity  and the surgeon’s experience, the conscious use of
ntibiotics  and pre- and postoperative care, as well as those
isk  factors associated with the patient.11,16
onclusion
owel transit reconstruction, although generally a procedure
uite  desired by the patient, is not free from complications.
herefore, one must always clarify the patient about the main
omplications, including the possibility of a lethal outcome.
n  addition, the dedicated team must take into account the
ontraindications of the procedure.
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